On January 8, 2019 Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, reported that the Company will host a business update call on Tuesday, January 15, 2019 (Press release, Advaxis, JAN 8, 2019, View Source [SID1234532566]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Advaxis’ senior management will host a conference call to provide a business update and to discuss fiscal year 2018 financial results, which will be released on January 10, 2019. The conference call and live audio webcast will begin at 11:00 a.m. Eastern time on Tuesday, January 15, 2019.

Conference Call & Webcast Information
WHEN: Tuesday, January 15, 2019 at 11:00 a.m. Eastern time
DOMESTIC DIAL-IN: (844) 348-6133
INTERNATIONAL DIAL-IN: (631) 485-4564
CONFERENCE ID: 4862946
WEBCAST: ir.advaxis.com/events-presentations

For those unable to participate in the live conference call or webcast, a digital recording will be available beginning January 15, 2019 two hours after the close of the conference call. To access the recording, please dial (855) 859-2056 for domestic callers or (404) 537-3406 for international callers and provide the operator with the conference ID: 4862946. In addition, an audio webcast will be archived on the Company’s website for a period of time at www.advaxis.com.